S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea flag South Korea · Delayed Price · Currency is KRW
24,000
-1,500 (-5.88%)
Last updated: Mar 28, 2025

S.Biomedics Statistics

Total Valuation

S.Biomedics has a market cap or net worth of KRW 271.33 billion. The enterprise value is 272.61 billion.

Market Cap 271.33B
Enterprise Value 272.61B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date Mar 21, 2025
Ex-Dividend Date n/a

Share Statistics

S.Biomedics has 11.75 million shares outstanding. The number of shares has increased by 5.15% in one year.

Current Share Class n/a
Shares Outstanding 11.75M
Shares Change (YoY) +5.15%
Shares Change (QoQ) +1.99%
Owned by Insiders (%) 22.14%
Owned by Institutions (%) 0.46%
Float 8.00M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 19.34
PB Ratio 22.87
P/TBV Ratio 23.68
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -40.74
EV / Sales 19.85
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -55.74

Financial Position

The company has a current ratio of 2.49, with a Debt / Equity ratio of 1.03.

Current Ratio 2.49
Quick Ratio 2.20
Debt / Equity 1.03
Debt / EBITDA n/a
Debt / FCF -3.84
Interest Coverage -6.84

Financial Efficiency

Return on equity (ROE) is -37.96% and return on invested capital (ROIC) is -11.07%.

Return on Equity (ROE) -37.96%
Return on Assets (ROA) -8.89%
Return on Invested Capital (ROIC) -11.07%
Return on Capital Employed (ROCE) -16.57%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.36
Inventory Turnover 2.99

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +104.78% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +104.78%
50-Day Moving Average 23,753.00
200-Day Moving Average 28,632.40
Relative Strength Index (RSI) 43.30
Average Volume (20 Days) 162,879

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, S.Biomedics had revenue of KRW 13.73 billion and -6.69 billion in losses. Loss per share was -582.00.

Revenue 13.73B
Gross Profit 6.71B
Operating Income -5.44B
Pretax Income -5.76B
Net Income -6.69B
EBITDA -3.72B
EBIT -5.44B
Loss Per Share -582.00
Full Income Statement

Balance Sheet

The company has 23.95 billion in cash and 18.78 billion in debt, giving a net cash position of 5.17 billion or 440.00 per share.

Cash & Cash Equivalents 23.95B
Total Debt 18.78B
Net Cash 5.17B
Net Cash Per Share 440.00
Equity (Book Value) 18.31B
Book Value Per Share 1,010.11
Working Capital 17.50B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.50 billion and capital expenditures -1.39 billion, giving a free cash flow of -4.89 billion.

Operating Cash Flow -3.50B
Capital Expenditures -1.39B
Free Cash Flow -4.89B
FCF Per Share -416.35
Full Cash Flow Statement

Margins

Gross margin is 48.84%, with operating and profit margins of -39.62% and -48.72%.

Gross Margin 48.84%
Operating Margin -39.62%
Pretax Margin -41.92%
Profit Margin -48.72%
EBITDA Margin -27.06%
EBIT Margin -39.62%
FCF Margin n/a

Dividends & Yields

S.Biomedics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -5.15%
Shareholder Yield -5.15%
Earnings Yield -2.47%
FCF Yield -1.80%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

S.Biomedics has an Altman Z-Score of 4.77.

Altman Z-Score 4.77
Piotroski F-Score n/a